PMID- 19412541 OWN - NLM STAT- MEDLINE DCOM- 20090817 LR - 20211020 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 4 IP - 5 DP - 2009 TI - Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects. PG - e5424 LID - 10.1371/journal.pone.0005424 [doi] LID - e5424 AB - BACKGROUND: Brain-derived neurotrophic factor (BDNF) is an activity-dependent secreted protein that is critical to organization of neuronal networks and synaptic plasticity, especially in the hippocampus. We tested hypothesis that reduced CSF BDNF is associated with age-related cognitive decline. METHODOLOGY/PRINCIPAL FINDINGS, AND CONCLUSIONS/SIGNIFICANCE: CSF concentration of BDNF, Abeta(42) and total tau were measured in 128 cognitively normal adults (Normals), 21 patients with Alzheimer's disease (AD), and nine patients with Mild Cognitive Impairment. Apolipoprotein E and BDNF SNP rs6265 genotype were determined. Neuropsychological tests were performed at baseline for all subjects and at follow-up visits in 50 Normals. CSF BDNF level was lower in AD patients compared to age-matched Normals (p = 0.02). CSF BDNF concentration decreased with age among Normals and was higher in women than men (both p<0.001). After adjusting for age, gender, education, CSF Abeta(42) and total tau, and APOE and BDNF genotypes, lower CSF BDNF concentration was associated poorer immediate and delayed recall at baseline (both p<0.05) and in follow up of approximately 3 years duration (both p<0.01). CONCLUSIONS/SIGNIFICANCE: Reduced CSF BDNF was associated with age-related cognitive decline, suggesting a potential mechanism that may contribute in part to cognitive decline in older individuals. FAU - Li, Ge AU - Li G AD - Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington, USA. gli@u.washington.edu FAU - Peskind, Elaine R AU - Peskind ER FAU - Millard, Steven P AU - Millard SP FAU - Chi, Peter AU - Chi P FAU - Sokal, Izabela AU - Sokal I FAU - Yu, Chang-En AU - Yu CE FAU - Bekris, Lynn M AU - Bekris LM FAU - Raskind, Murray A AU - Raskind MA FAU - Galasko, Douglas R AU - Galasko DR FAU - Montine, Thomas J AU - Montine TJ LA - eng GR - R01 AG023185/AG/NIA NIH HHS/United States GR - U01 AG016976/AG/NIA NIH HHS/United States GR - AG023185/AG/NIA NIH HHS/United States GR - P50 AG005136/AG/NIA NIH HHS/United States GR - P50-AG005136/AG/NIA NIH HHS/United States GR - AG05136/AG/NIA NIH HHS/United States GR - P50 AG005136-26/AG/NIA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20090501 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Amyloid beta-Peptides) RN - 0 (Apolipoproteins E) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Peptide Fragments) RN - 0 (amyloid beta-protein (1-42)) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Alzheimer Disease/cerebrospinal fluid/genetics/psychology MH - Amyloid beta-Peptides/cerebrospinal fluid MH - Apolipoproteins E/genetics MH - Brain-Derived Neurotrophic Factor/*cerebrospinal fluid/genetics MH - Case-Control Studies MH - Cognition/*physiology MH - Cognition Disorders/cerebrospinal fluid/genetics/psychology MH - Cross-Sectional Studies MH - Female MH - Genotype MH - Humans MH - Longitudinal Studies MH - Male MH - Memory/physiology MH - Middle Aged MH - Neuropsychological Tests MH - Peptide Fragments/cerebrospinal fluid MH - Young Adult PMC - PMC2671606 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2009/05/05 09:00 MHDA- 2009/08/18 09:00 PMCR- 2009/05/01 CRDT- 2009/05/05 09:00 PHST- 2009/01/25 00:00 [received] PHST- 2009/04/01 00:00 [accepted] PHST- 2009/05/05 09:00 [entrez] PHST- 2009/05/05 09:00 [pubmed] PHST- 2009/08/18 09:00 [medline] PHST- 2009/05/01 00:00 [pmc-release] AID - 09-PONE-RA-08373R1 [pii] AID - 10.1371/journal.pone.0005424 [doi] PST - ppublish SO - PLoS One. 2009;4(5):e5424. doi: 10.1371/journal.pone.0005424. Epub 2009 May 1.